
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
KRTAP14 CRISPR/Cas9 KO Plasmid (m) | sc-423901 | 20 µg | $397.00 |
Krtap14 encodes keratin-associated protein 14, a small cysteine-rich structural component of the hair shaft matrix in mouse that contributes to the mechanical strength and crosslinking of keratin intermediate filaments. KRTAP14 participates in terminal differentiation programs of hair follicle keratinocytes and is integrated into processes governing hair fiber assembly, cuticle/cortex organization, and disulfide bond–mediated stabilization. Altered expression or structural variation in keratin-associated proteins is linked to changes in hair texture and fragility phenotypes, making Krtap14 relevant for studying hair shaft integrity and follicular biology. Its expression is often considered alongside keratinization networks and epidermal differentiation complex–associated pathways that shape appendage formation.
KRTAP14 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Krtap14 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Krtap14 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Krtap14 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish KRTAP14 protein expression.
This CRISPR knockout system enables efficient generation of Krtap14-deficient cell models for investigation of KRTAP14 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.